Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Retina ; 44(7): 1196-1202, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38437826

RESUMEN

PURPOSE: To compare topical nonsteroidal anti-inflammatory drug (NSAID) efficacy on intravitreal injection-induced pain reduction and determine the most efficient topical NSAID. METHODS: This randomized-controlled study included 662 eyes of 662 patients. Based on the types of NSAID administered before intravitreal injection, eight subgroups were formed. In the control group, a sterile saline solution was applied instead of NSAIDs. The visual analog scale was used to assess pain scores after intravitreal injection. The visual analog scale scores were noted immediately and 6 hours following injection (sixth hour). RESULTS: Nepafenac 0.3%, nepafenac 0.1%, and bromfenac 0.09% had the lowest scores, immediately after and after 6 hours, with no significant differences. Diclofenac and ketorolac had higher visual analog scale scores than the first trio but lower scores than the control group. Flurbiprofen, pranoprofen, and indomethacin did not significantly affect immediate pain; however, at the sixth hour, the visual analog scale scores were significantly reduced. CONCLUSION: Nepafenac 0.3%, nepafenac 0.1%, and bromfenac 0.09% were the most effective NSAIDs for pain reduction. Although some NSAIDs did not have a significant effect on immediate pain, they all provided significant benefits at the sixth hour.


Asunto(s)
Antiinflamatorios no Esteroideos , Bencenoacetamidas , Dolor Ocular , Inyecciones Intravítreas , Fenilacetatos , Antiinflamatorios no Esteroideos/administración & dosificación , Humanos , Masculino , Femenino , Dolor Ocular/prevención & control , Dolor Ocular/diagnóstico , Dolor Ocular/tratamiento farmacológico , Anciano , Fenilacetatos/administración & dosificación , Persona de Mediana Edad , Bencenoacetamidas/administración & dosificación , Benzofenonas/administración & dosificación , Bromobencenos/administración & dosificación , Administración Tópica , Dimensión del Dolor , Soluciones Oftálmicas , Ketorolaco/administración & dosificación , Anciano de 80 o más Años
2.
J Vet Pharmacol Ther ; 47(3): 175-186, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38235901

RESUMEN

We evaluated the effect of administration timing of meloxicam and robenacoxib on renal function, platelet cyclo-oxygenase and perioperative analgesia in 60 cats undergoing ovariohysterectomy, in a prospective randomized blinded controlled study. Twelve cats were randomly allocated to one subcutaneous treatment group: meloxicam (0.2 mg/kg) or robenacoxib (2 mg/kg) at admission (MA, RA), at induction (MI, RI) and robenacoxib at the end of surgery (RE). All cats received the same anaesthesia protocol. Plasma renin activity (PRA), plasma creatinine, drug concentrations and serum thromboxane (TxB2) were measured sequentially. Anaesthesia significantly increased PRA, as activity at end of the surgery was higher than 2 h later (mean ± SD: 26.6 ± 2.8 versus 10.0 ± 3.9 ng/mL/h). PRA remained higher at 2 h post-surgery in admission groups compared to induction groups (p = .01). Serum TxB2 was lower with meloxicam than robenacoxib (p = .001), and was lower in the MA than each robenacoxib group at catheter placement. Admission groups (16/24 from RA and MA groups) received earlier rescue analgesia than other groups (p = .033). In conclusion, the renin-angiotensin system was activated during anaesthesia despite cyclo-oxygenase inhibition, possibly due to hypotension or surgical stimulation. There was no effect of drug or timing on the markers of renal function but one cat receiving meloxicam at induction had suspected IRIS grade II acute kidney injury.


Asunto(s)
Difenilamina , Histerectomía , Meloxicam , Ovariectomía , Dolor Postoperatorio , Fenilacetatos , Animales , Gatos , Femenino , Analgesia/veterinaria , Analgesia/métodos , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Difenilamina/farmacología , Difenilamina/administración & dosificación , Difenilamina/análogos & derivados , Histerectomía/veterinaria , Riñón/efectos de los fármacos , Meloxicam/administración & dosificación , Meloxicam/farmacología , Meloxicam/uso terapéutico , Ovariectomía/veterinaria , Dolor Postoperatorio/veterinaria , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/prevención & control , Fenilacetatos/administración & dosificación , Fenilacetatos/farmacología
3.
Arq. bras. oftalmol ; 83(2): 149-152, Mar.-Apr. 2020. graf
Artículo en Inglés | LILACS | ID: biblio-1088967

RESUMEN

ABSTRACT Gyrate atrophy is a rare metabolic autosomal recessive disorder caused by ornithine aminotransferase enzyme deficiency that leads to characteristic progressive, degenerative chorioretinal findings. Patients complain mostly of low vision, night blindness, and peripheral vision loss. Posterior subcapsular cataract, myopia, choroid neovascularization, and intraretinal cysts may be accompanying factors related to vision loss. We encountered a patient with vision loss secondary to posterior subcapsular cataract and intraretinal cysts. After treatment with topical brinzolamide and nepafenac (and without any diet mo dification and/or supplementation), we observed 143- and 117-mm macular thickness resolutions with 2 and 1 Snellen lines of visual gain in his right and left eyes, respectively. Also, we detected a novel homozygous mutation in the ornithine aminotransferase gene: c.1253T>C (p.Leu418Pro). Carbonic anhydrase inhibitors and/or non-steroid anti-inflammatory drugs can control macular edema in patients with gyrate atrophy-associated intraretinal cysts. The genetic variants may also be a determinant in the responsiveness to the therapy type.


RESUMO A atrofia girata é um distúrbio autossômico recessivo metabólico raro causado pela deficiência da enzima ornitina ami notransferase, que leva a achados degenerativos coriorretinianos progressivos característicos. Os pacientes queixam-se principalmente de baixa visão, cegueira noturna e perda de vi são periférica. A catarata subcapsular posterior, a miopia, a neovascularização da coróide e os cistos intrarretinianos podem ser fatores associados à perda da visão. Encontramos um paciente com perda de visão secundária à catarata subcapsular posterior e cistos intrarretinianos. Após o tratamento com brinzolamida tópica e nepafenaco (e sem modificação e/ou suplementação da dieta), observamos resoluções de espessura macular de 143 e 117 mm e com 2 e 1 linhas de Snellen de ganho visual nos olhos direito e esquerdo, respectivamente. Além disso, detectamos uma nova mutação homozigótica no gene da ornitina aminotransfera se: c.1253T>C (p.Leu418Pro). Inibidores da anidrase carbônica e/ou drogas anti-inflamatórias não esteróides podem controlar o edema macular em pacientes com cistos intrarretinianos associados à atrofia girata. As variantes genéticas também podem ser determinantes na responsividade ao tipo de terapia.


Asunto(s)
Humanos , Masculino , Adulto , Fenilacetatos/administración & dosificación , Inhibidores de Anhidrasa Carbónica/administración & dosificación , Atrofia Girata/genética , Antiinflamatorios no Esteroideos/administración & dosificación , Edema Macular/tratamiento farmacológico , Bencenoacetamidas/administración & dosificación , Ornitina-Oxo-Ácido Transaminasa/genética , Sulfonamidas/administración & dosificación , Tiazinas/administración & dosificación , Angiografía con Fluoresceína , Edema Macular/diagnóstico por imagen , Tomografía de Coherencia Óptica , Secuenciación de Nucleótidos de Alto Rendimiento , Administración Oftálmica , Mutación
4.
Rev. bras. oftalmol ; 73(5): 269-272, Sep-Oct/2014. tab, graf
Artículo en Portugués | LILACS | ID: lil-741899

RESUMEN

Objetivo: Avaliar o efeito preemptivo com nepafenaco 0,1% em pacientes submetidos à fotocoagulação da retina para tratamento da retinopatia diabética proliferativa. Métodos: Trinta pacientes foram submetidos à fotocoagulação com laser de argônio em ambos os olhos. O olho contralateral de cada paciente foi o controle. O nepafenaco e o placebo foram utilizados 30 minutos antes da aplicação do laser. Ambos os olhos foram fotocoagulados no mesmo dia. A intensidade da dor foi avaliada por meio da escala analógica visual e da escala descritiva de dor. Resultados: A análise da interação instilação versus nepafenaco mostrou que os pacientes do grupo placebo apresentaram níveis de dor semelhantes em ambos os olhos, e os do grupo nepafenaco apresentaram redução importante do nível de dor no olho em que foi instilado a suspensão de 0,1% quando comparado ao olho contralateral que recebeu placebo (p=0,023). Conclusão: Este estudo sugere que a suspensão de 0,1% de nepafenaco foi útil na analgesia preemptiva de pacientes submetidos à fotocoagulação de retina quando comparada ao placebo. .


Objective: To evaluate the preemptive effect of nepafenac 0,1% in patients undergoing retinal photocoagulation for the treatment of proliferative diabetic retinopathy Methods: Thirty patients underwent argon laser photocoagulation in both eyes. The contralateral eye of each patient was the control. The nepafenac and placebo were used 30 minutes before the application of the laser. Both eyes were photocoagulated in the same day. Pain intensity was assessed by visual analog scale and descriptive pain scale Results: The analysis of the interaction instillation versus nepafenac showed that patients in the placebo group had similar levels of pain in both eyes, and the nepafenac group had significant reduction in pain in the eye that was instilled suspension of 0,1% when compared to the contralateral eye which received placebo (p = 0.023). Conclusion: This study suggests that a suspension of 0,1% nepafenac helpful for preemptive analgesia in patients undergoing retinal photocoagulation compared to placebo. .


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Dolor Postoperatorio/prevención & control , Fenilacetatos/administración & dosificación , Dimensión del Dolor/métodos , Antiinflamatorios no Esteroideos/administración & dosificación , Coagulación con Láser/métodos , Retinopatía Diabética/cirugía , Dolor/tratamiento farmacológico , Argón/uso terapéutico , Medicación Preanestésica , Instilación de Medicamentos , Distribución Aleatoria , Estudios de Casos y Controles , Método Doble Ciego , Estudios Prospectivos , Encuestas y Cuestionarios , Vitreorretinopatía Proliferativa/cirugía , Bencenoacetamidas/administración & dosificación , Percepción del Dolor/efectos de los fármacos , Escala Visual Analógica , Analgesia/métodos
5.
Hist. ciênc. saúde-Manguinhos ; 21(4): 1179-1196, Oct-Dec/2014.
Artículo en Portugués | LILACS | ID: lil-732513

RESUMEN

O artigo analisa o livro Boys in white: student culture in medical school, de Howard S. Becker, Blanche Geer, Everett C. Hughes e Anselm Strauss, considerado um dos modelos de pesquisa qualitativa em sociologia. A análise aborda as trajetórias dos autores, do livro, da pesquisa qualitativa e dos estudantes de medicina, enfatizando sua importância nas origens da sociologia médica e da sociologia da educação médica. Na trajetória dos autores são apresentados aspectos biobibliográficos; na da pesquisa qualitativa, o modo como essa metodologia de investigação atravessa a construção do trabalho de campo; e na dos estudantes, sua forma de atravessar os primeiros anos da escola médica e construir sua própria “cultura do estudante”.


This article analyzes Boys in white: student culture in medical schoolby Howard S. Becker, Blanche Geer, Everett C. Hughes and Anselm Strauss, considered a model of qualitative research in sociology. The analysis investigates the trajectories of the authors, the book, qualitative analysis, and the medical students, emphasizing their importance in the origins of medical sociology and the sociology of medical education. In the trajectory of the authors, bibliographical information is given. The trajectory of qualitative research focuses on how this methodology influences the construction of the field. The investigation of the students’ trajectory shows how they progress through their first years at medical school to build their own student culture.


Asunto(s)
Animales , Femenino , Ratones , Adenocarcinoma/tratamiento farmacológico , Antimetabolitos Antineoplásicos/farmacología , Antineoplásicos Hormonales/farmacología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Apoptosis/efectos de los fármacos , Neoplasias de la Mama/tratamiento farmacológico , Estrógenos , Antagonistas de Estrógenos/farmacología , Inhibidores de Crecimiento/farmacología , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Fenilacetatos/farmacología , /biosíntesis , Tamoxifeno/farmacología , Adenocarcinoma/patología , Antimetabolitos Antineoplásicos/administración & dosificación , Antineoplásicos Hormonales/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Neoplasias de la Mama/patología , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Sinergismo Farmacológico , Genes ras , Ratones Desnudos , Trasplante de Neoplasias , Neoplasias Hormono-Dependientes/patología , /fisiología , Fenilacetatos/administración & dosificación , /genética , Transfección , Tamoxifeno/administración & dosificación , Células Tumorales Cultivadas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA